A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo
Skin Research and Technology · 2024
DOI: 10.1111/srt.13642 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Alireza Jafarzadeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical …. Hauptthemen laut MEDLINE: Vitiligo, Hypopigmentation, Purines, Pyrazoles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims and objectives The purpose of this study is to investigate the effectiveness and safety of oral and injectable systemic treatments, such as methotrexate, azathioprine, cyclosporine, tofacitinib, baricitinib, corticosteroids, statins, zinc, apremilast, etc., for treating vitiligo lesions.
Method
Databases including PubMed, Scopus, and Web of Science were meticulously searched for studies spanning from 2010 to August 2023, focusing on systemic oral and injectable therapies for vitiligo, using comprehensive keywords and search syntaxes tailored to each database. Key data extracted included study design, treatment efficacy, patient outcomes, patient satisfaction, and safety profiles.
Results
In a total of 42 included studies, oral mini‐pulse corticosteroid therapy (OMP) was the subject of six studies (14.2%). Minocycline was the focus of five studies (11.9%), while methotrexate, apremilast, and tofacitinib each were examined in four studies (9.5%). Antioxidants and Afamelanotide were the subjects of three studies each (7.1%). Cyclosporine, simvastatin, oral zinc, oral corticosteroids (excluding OMP) and injections, and baricitinib were each explored in two studies (4.8%). Azathioprine, mycophenolate mofetil, and Alefacept were the subjects of one study each (2.4%).
Conclusion
Systemic treatments for vitiligo have been successful in controlling lesions without notable side effects. OMP, Methotrexate, Azathioprine, Cyclosporine, Mycophenolate mofetil, Simvastatin, Apremilast, Minocycline, Afamelanotide, Tofacitinib, Baricitinib, Antioxidants, and oral/injectable corticosteroids are effective treatment methods. However, oral zinc and alefacept did not show effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
- Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
ORCID-Profile: Alireza Jafarzadeh, Mina Khosravi, Asma Rasouli, Azadeh Goodarzi
Zitieren
APA
Jafarzadeh, A., Pour Mohammad, A., Khosravi, M., Amiri, S., Rasouli, A., Keramati, H., & Goodarzi, A. (2024). A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo. Skin Research and Technology. https://doi.org/10.1111/srt.13642
Vancouver
Jafarzadeh A, Pour Mohammad A, Khosravi M, Amiri S, Rasouli A, Keramati H, et al. A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo. Skin Research and Technology. 2024. doi:10.1111/srt.13642
BibTeX
@article{Jafarzadeh2024,
author = {Jafarzadeh, Alireza and Pour Mohammad, Arash and Khosravi, Mina and Amiri, Shila and Rasouli, Asma and Keramati, Haniyeh and Goodarzi, Azadeh},
title = {A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo},
journal = {Skin Research and Technology},
year = {2024},
doi = {10.1111/srt.13642}
}
EUVIMED